Filing Details
- Accession Number:
- 0001127602-23-023362
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-29 16:23:42
- Reporting Period:
- 2023-08-24
- Accepted Time:
- 2023-08-29 16:23:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc. | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1198092 | F Richard Wallman | 251 Ballardvale Street Wilmington MA 01887 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-08-24 | 1,000 | $198.79 | 1,000 | No | 4 | P | Indirect | By Wife |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Wife |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 22,528 | Direct |
Footnotes
- The shares were acquired in 4 transactions ranging in price from $198.70 to $198.85. The reporting person will provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.